A Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects
Clinical trial NCT02859207 · COMPLETED
Trial details
- NCT number
- NCT02859207
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2016-12-06
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.